Publications by authors named "Edwin Gale"

Claim this Profile
T
The moral equivalent: 60 years of publishing a scientific journal.
Edwin Gale, George Alberti, Ele Ferrannini, Sally Marshall, Juleen R Zierath

Diabetologia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macleod Before Banting.
Edwin Gale

Can J Health Hist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teplizumab approval for type 1 diabetes in the USA.
David Beran, Carol Abidha, Amanda Adler, Carine de Beaufort, Molly Lepeska, Edwin Am Gale

Lancet Diabetes Endocrinol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The insulin market reaches 100.
David Beran, Edwin A M Gale, John S Yudkin

Diabetologia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing type 1 diabetes with stem cell-derived islets: a step closer to the dream?
Peter C Butler, Edwin Am Gale

J Clin Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and the WHO Model List of Essential Medicines.
David Beran, Stéphane Besançon, Margaret Ewen, Edwin A M Gale, Maria Lazo-Porras

Lancet Diabetes Endocrinol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Winner's curse: The sad aftermath of the discovery of insulin.
James R Wright, Edwin A M Gale

Diabet Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in sub-Saharan Africa: from clinical care to health policy.
Rifat Atun, Justine I Davies, Edwin A M Gale, Till Bärnighausen, David Beran

Lancet Diabetes Endocrinol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential medicines and access to insulin.
Geoff Gill, John S Yudkin, Solomon Tesfaye, Maximilian de Courten, Edwin Gale

Lancet Diabetes Endocrinol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of diabetes in sub-Saharan Africa.
Rifat Atun, Edwin A M Gale

Lancet Diabetes Endocrinol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity of authors in the field of diabetes: bibliographic analysis of trial publications.
Frits Holleman, Mick Uijldert, Lennart F Donswijk, Edwin A M Gale

BMJ· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoke or fire? Acute pancreatitis and the liraglutide trials.
Edwin A M Gale

Diabetes Care· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125.
Edwin A M Gale

Diabetes Care· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: the hedgehog and the fox: Sir Harold Himsworth (1905-93).
Edwin A H Gale

Int J Epidemiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?
Peter C Butler, Michael Elashoff, Robert Elashoff, Edwin A M Gale

Diabetes Care· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can NICE prevent diabetes?
Edwin A M Gale

Heart· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is type 2 diabetes a category error?
Edwin A M Gale

Lancet· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incretin therapy: should adverse consequences have been anticipated?
Edwin Gale

BMJ· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm.
Edwin A M Gale

BMJ· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Diabetes Federation: losing its credibility by partnering with Nestlé?
David Beran, Simon Capewell, Maximilian de Courten, Edwin Gale, Geoffrey Gill

Lancet· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newer insulins in type 2 diabetes.
Edwin A M Gale

BMJ· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing studies of new insulins: sales or science?
Edwin A M Gale

BMJ· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?
Edwin A M Gale

Diabetes· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.
Craig J Currie, Chris D Poole, Sara Jenkins-Jones, Edwin A M Gale, Jeffrey A Johnson

Diabetes Care· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADDITION-Europe and the case for diabetes screening.
John S Yudkin, Victor M Montori, Kasia J Lipska, Edwin A M Gale

Lancet· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis